Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Otoraplin ELISA Kit (AC2537)
Cat.#: ASET-1126
Specifications
Description Human Otoraplin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Otoraplin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 1.64 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 30-480 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1635 Mouse CX3CR1 ELISA Kit (AC3046) Quantitative inquiry ASET-1206 Human Substance P ELISA Kit (AC2617) Quantitative inquiry ASET-1468 Sheep IL-6 ELISA Kit (AC2879) Quantitative inquiry ASET-2254 Mouse Neuropeptide S ELISA Kit (AC3665) Quantitative inquiry ASET-2457 Human Neurofascin ELISA Kit (AC3868) Quantitative inquiry ASET-2113 Rat NT-4 ELISA Kit (AC3524) Quantitative inquiry ASET-1602 Mouse SYN2 ELISA Kit (AC3013) Quantitative inquiry ASET-1833 Human Ferritin Heavy Chain ELISA Kit (AC3244) Quantitative inquiry ASET-2167 Rat AHSG ELISA Kit (AC3578) Quantitative inquiry ASET-2076 Human EDG8 ELISA Kit (AC3487) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket